Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues VLRS Q1 2026 Earnings EPS Beat Provides Margin of Relief Amid Cost Pressures FOR Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Stock Gains 36 PVL Q1 2023 Earnings Trust Reports EPS of 013 Amid Energy Royalty Trends ECL Q1 2026 Earnings Slight EPS Miss Amid Steady Performance Shares Edge Higher CIEN Q1 2026 Earnings Solid EPS Beat Despite Revenue Caution Stock Edges Up